Table 4.
Frequency of clinical high risk criteria in age groups and sexes, n (% of group)
| Any CHR criterion | Any EPA criterion | COPER | COGDIS | APSS | BIPSS | GRDS, only by family history | |
| 8-12 yr | 7 (6.0) | 5 (4.3) | 2 (1.7) | 1 (0.9) | 4 (3.4) | 0 | 0 |
| 13-15 yr | 5 (7.2) | 4 (5.8) | 3 (4.3) | 3 (4.3) | 1 (1.4) | 0 | 0 |
| 16-17 yr | 9 (4.7) | 1 (0.5) | 9 (4.7) | 1 (0.5) | 0 | 0 | 0 |
| 18-19 yr | 5 (3.0) | 3 (1.8) | 4 (2.4) | 3 (1.8) | 1 (0.6) | 0 | 0 |
| 20-24 yr | 19 (3.9) | 11 (2.2) | 12 (2.4) | 3 (0.6) | 8 (1.8) | 1 (0.2) | 0 |
| 25-29 yr | 4 (1.3) | 1 (0.3) | 3 (0.9) | 0 | 1 (0.3) | 0 | 0 |
| 30-40 yr | 33 (2.1) | 13 (0.8) | 30 (1.9) | 10 (0.6) | 5 (0.3) | 0 | 0 |
| Male | 29 (1.9) | 13 (0.8) | 22 (1.4) | 6 (0.4) | 9 (0.6) | 0 | 0 |
| Female | 53 (3.9) | 25 (1.8) | 41 (3.0) | 15 (1.1) | 11 (0.8) | 1 (0.1) | 0 |
| Total | 82 (2.8) | 38 (1.3) | 63 (2.2) | 21 (0.7) | 20 (0.7) | 1 (0.03) | 0 |
CHR: Clinical high risk; EPA: European Psychiatric Association; COPER: Cognitive-Perceptive Basic Symptoms; COGDIS: Cognitive Disturbances; APSS: Attenuated Psychotic Symptoms Syndrome; BIPSS: Brief Intermittent Psychotic Symptoms Syndrome; GRDS: Genetic Risk and Deterioration Syndrome.